Manoj P. Dandekar1, Alexandre P. Diaz2
, Ziaur Rahman1, Ritele H. Silva3, Ziad Nahas4, Scott Aaronson5, Sudhakar Selvaraj2
, Albert J. Fenoy2,6
, Marsal Sanches2, Jair C. Soares2,7, Patricio Riva-Posse8, Joao Quevedo2,3,7,9
DOI: 10.1590/1516-4446-2021-1874
Epub: August 30 2021
1Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India
2Center of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA
3Laboratório de Psiquiatria Translacional, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
4Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA
5Clinical Research Programs, Sheppard Pratt Health System, Baltimore, MD, USA
6Deep Brain Stimulation Program, Department of Neurosurgery, McGovern Medical School, UTHealth, Houston, TX, USA
7Neuroscience Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA
8Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA
9Translational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth, Houston, TX, USA